SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001477932-23-000494 from GUIDED THERAPEUTICS INC (GTHP) (CIK 0000924515) (GTHP)

GUIDED THERAPEUTICS INC (GTHP) (CIK 0000924515)
Date: Jan. 23, 2023 · CIK: 0000924515 · Accession: 0001477932-23-000494

AI Filing Summary & Sentiment

File numbers found in text: 333-269229

Date
January 23, 2023
Author
/s/ Gene S. Cartwright
Form
CORRESP
Company
GUIDED THERAPEUTICS INC (GTHP) (CIK 0000924515)

Letter

VIA EDGAR Division of Corporation Finance Office of Industrial Applications and Services Guided Therapeutics, Inc. Registration Statement on Form S-1 Filed January 13, 2023 File No. 333-269229

Dear Mr. Richie:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Guided Therapeutics, Inc. hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 4:00 p.m. ET on Wednesday, January 25, 2023, or as soon as thereafter practicable.

Very truly yours,
/s/ Gene S. Cartwright

Show Raw Text
CORRESP
1
filename1.htm

gthp_corresp.htmGuided Therapeutics, Inc.

 15835 Peachtree Corners East, Suite B

 Norcross, Georgia 30092

 January 23, 2023

 VIA EDGAR

 Benjamin Richie

 Division of Corporation Finance

 Office of Industrial Applications and Services

 U.S. Securities and Exchange Commission

 100 F Street, NE

 Washington, D.C. 20549-4561

     Re:

   Guided Therapeutics, Inc.

   Registration Statement on Form S-1

   Filed January 13, 2023

   File No. 333-269229

 Dear Mr. Richie:

 Pursuant to Rule 461 under the Securities Act of 1933, as amended, Guided Therapeutics, Inc. hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 4:00 p.m. ET on Wednesday, January 25, 2023, or as soon as thereafter practicable.

   Very truly yours,

   /s/ Gene S. Cartwright

   Gene S. Cartwright

   Chief Executive Officer

     cc:

   Ellenoff Grossman & Schole LLP